Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
14.38 USD | -1.61% | -0.83% | +33.64% |
21/05 | Immunome Insider Bought Shares Worth $1,388,072, According to a Recent SEC Filing | MT |
20/05 | Immunome Completes Purchase of Antibodies From Atreca | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+33.64% | 88Cr | |
+8.88% | 12TCr | |
+9.39% | 10TCr | |
-13.06% | 2.27TCr | |
+2.39% | 2.18TCr | |
-10.88% | 1.82TCr | |
-41.92% | 1.65TCr | |
-16.52% | 1.6TCr | |
+1.28% | 1.41TCr | |
+16.83% | 1.07TCr |
- Stock Market
- Equities
- IMNM Stock
- News Immunome, Inc.
- Immunome Appoints Dennis Giesing as Chief Development Officer